Career Development Committee
The Career Development Committee serves as a resource to the organization and members seeking guidance and advice about potential career pathways. The committee also helps with leadership development for CAHON members.
Hongtao Liu, MD, PhD (Chair)
Hongtao Liu is a hematologist, specializing in the diagnosis and treatment of leukemia, stem cell transplantation and cellular therapy. Dr. Liu is currently an associate professor of medicine at the University of Wisconsin-Madison, directing the program of stem cell transplant and cellular therapy. He received MD and Ph.D. in immunology from Beijing Medical University, he finished his hematology/oncology fellowship training at University of Chicago. Dr. Liu aims to develop novel therapies to fight leukemia and prevent disease relapse. He is an active member of ASH, ASCO, ASBMT and CAHON.
Mary Li, MD, PhD (Co-Chair)
Dr. Mary Li is a board-certified oncologist for Florida Cancer Specialists & Research Institute (FCS) in Hernando County. Often described as outgoing and always positive about life, she is devoted to her work as an oncologist, to patient care and to her family.
Dr. Li maintains a keen focus on cutting edge cancer treatments and remains steadfastly involved in clinical research. She is the author of numerous publications in Neuropharmacology and has special interest in DNA adducts and carcinogens.
After earning her doctorate in Pharmacology, Dr. Li completed the internship and residency program in Internal Medicine at the University of Louisville, where she received recognition as Best Resident and Chief Resident in Internal Medicine, and Chief Fellow in Medical Oncology. She is Board-certified in Medical Oncology and Internal Medicine.
Dr. Li joined Florida Cancer Specialists in 2011. She serves on the FCS Executive Board and is a member of the Compliance Committee.
Ranked as a Top Oncologist by Consumers’ Research Council of America in 2010, Dr. Li was nominated by her patients as a candidate for the Lymphoma & Leukemia Society Woman of the Year in 2013. She is an active supporter and advocate for many cancer organizations, including the American Cancer Society. Dr. Li travels frequently on weekends to keep up with information on cutting-edge new treatments for her patients.
In her spare time, Dr. Li enjoys all kinds of outdoor activities and spending time with her family.
Jane Liu, MD
Dr. Liu is a Hematologist/Oncologist at Illinois Cancer Care, P.C. (ILCC). She received her medical degree from Peking University Health Science Center in Beijing, China. Dr. Liu worked as a research scientist at Amgen Inc. from 2001-2006. She completed her Internal Medicine residency at University of Southern California in Los Angeles, California. Her Hematology/Oncology fellowships were completed at H. Lee Moffitt Cancer Center in Tampa, Florida. Dr. Liu joined ILCC in 2012, practicing general Hematology and Oncology with focuses on lung cancer and leukemia.
Dr. Liu is passionate about clinical and translational research in the community setting. Since the beginning of the NCI Community Oncology Research Program (NCORP), she has served as the local PI for the Heartland NCORP and has been among the top accruing investigators. She also serves on the Alliance community oncology committee, Cancer Care Delivery Research committee, and ASCO Research Community Forum Council.She is a lifetime member of CAHON since 2014 and has been active in participating in CAHON’s community practice activities. She also has interest and expertise in medical informatics and practice management.
Lei Deng, MD
Dr. Lei Deng is a thoracic medical oncologist and assistant professor at the University of Washington and Fred Hutchinson Cancer Center, Seattle, WA. He has been involved in thoracic oncology research since he was a medical student. He is a member of the Career Development Committee at International Association for the Study of Lung Cancer (IASLC). In Seattle, his research focuses on clinical and translational studies in non-small cell lung cancer with KRAS mutations as well as patients with non-metastatic disease.
Haoran Li, MD, PhD
Haoran Li, MD, PhD is an Assistant Professor in the Division of Medical Oncology at the University of Kansas Cancer Center. He received his MD from Sun Yat-Sen University's Zhong Shan School of Medicine, followed by a residency in Medical Oncology at Sun Yat-sen Cancer Center. Dr. Li furthered his education with a PhD in Laboratory Medicine & Pathobiology at the University of Toronto. His postdoctoral training included roles as a Clinical Research Fellow at the University of Ottawa's The Ottawa Hospital and as a Visiting Physician at the University of Calgary's Tom Baker Cancer Center in Canada. Subsequently, he completed an Internal Medicine Residency at Weill Cornell Medical College, Lincoln Medical Center in New York, and a Fellowship at Huntsman Cancer Institute, University of Utah.
Dr. Li has made substantial contributions to oncology literature, publishing extensively in esteemed journals such as JAMA, JAMA Netw Open, Eur Urol Oncol, Eur Urol Focus and Oncologist, focusing primarily on genitourinary cancers and immunotherapy-related toxicities. His research abilities are further underscored by his involvement in presentations for major conferences like ASCO and NCCN. Dr. Li has also contributed chapters to notable books, discussing topics ranging from neurotoxicity associated with immune checkpoint inhibitors to stress response pathways in cancer.
Throughout his career, Dr. Li has been recognized with numerous honors and awards, including Merit Award at ASCO and the Outstanding Research Award from Genitourinary Medical Oncologists of Canada. He is fluent in English, Mandarin, Cantonese. Dr. Li is committed to advancing cancer care and research, as evidenced by his active participation in conferences worldwide and his comprehensive approach to patient care and scientific inquiry.
Eric Chen, MD, PhD
Dr. Chen is a staff physician at the Department of Medical Oncology and Hematology, Princess Margaret Cancer Center, University Health Network, Toronto, Canada, and Professor, Faculty of Medicine, University of Toronto. His clinical activities focus on the treatment of gastrointestinal cancers. He participates in clinical trials evaluating new agents and treatment strategies for gastrointestinal cancers.